Andrew R. Allen

Insider Reports History

Location
Boulder, CO
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew R. Allen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Gritstone bio, Inc. PRESIDENT AND CEO, Director Common Stock 1,124,275 $841,295 $0.7483 24 Jun 2024 Indirect
Gritstone bio, Inc. PRESIDENT AND CEO, Director Common Stock 985,360 $737,345 $0.7483 24 Jun 2024 Direct
Gritstone bio, Inc. PRESIDENT AND CEO, Director Common Stock 325,000 $243,198 $0.7483 24 Jun 2024 Allen 2024 Gift Trust
Epizyme, Inc. Director Common Stock, par value $0.0001 20,560 $28,990 $1.41 11 Jun 2021 Direct
Epizyme, Inc. Director Stock Option (Right to Buy) 40,559 $22,713 $0.5600 11 Jun 2021 Direct
Adaptimmune Therapeutics PLC Director Option to purchase Ordinary Shares 660,000 01 Jul 2024 Direct
Gritstone bio, Inc. PRESIDENT AND CEO, Director Stock Option (Right to Buy) 615,000 15 May 2024 Direct
Cullinan Therapeutics, Inc. Director Stock Option (Right to Buy) 79,456 07 Aug 2025 Direct
Sierra Oncology, Inc. Director, 10%+ Owner Common Stock 0 $55.00 01 Jul 2022 Direct
Sierra Oncology, Inc. Director, 10%+ Owner Stock Option (right to buy) 0 01 Jul 2022 Direct
TCR2 THERAPEUTICS INC. Director Stock Option (Right to Buy) 0 $0.7400 01 Jun 2023 Direct

Insider Reports Filed by Andrew R. Allen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CGEM Cullinan Therapeutics, Inc. 07 Aug 2025 1 $0 4 Director 08 Aug 2025, 17:30
CGEM Cullinan Therapeutics, Inc. 07 Aug 2025 0 $0 3 Director 08 Aug 2025, 17:30
ADAP Adaptimmune Therapeutics PLC 01 Jul 2024 1 $0 4 Director 01 Jul 2024, 17:00
/report/000141588924018275-allen-andrew-r-2024-06-24 Gritstone bio, Inc. 24 Jun 2024 2 $0 4 PRESIDENT AND CEO, Director 26 Jun 2024, 21:25
/report/000141588924013657-allen-andrew-r-2024-05-15 Gritstone bio, Inc. 15 May 2024 3 -$18,156 4 PRESIDENT AND CEO, Director 17 May 2024, 21:58
/report/000141588924002702-allen-andrew-r-2024-02-01 Gritstone bio, Inc. 01 Feb 2024 2 $0 4 PRESIDENT AND CEO, Director 05 Feb 2024, 18:57
ADAP Adaptimmune Therapeutics PLC 05 Jul 2023 6 $0 4 Director 05 Jul 2023, 17:03
ADAP Adaptimmune Therapeutics PLC 03 Jul 2023 1 $0 4 Director 03 Jul 2023, 17:00
ADAP Adaptimmune Therapeutics PLC 01 Jun 2023 0 $0 3 Director 01 Jun 2023, 16:46
/report/000110465923067082-allen-andrew-r-2023-06-01 TCR2 THERAPEUTICS INC. 01 Jun 2023 6 $0 4 Director 01 Jun 2023, 16:33
/report/000156761923001941-allen-andrew-r-2023-02-02 Gritstone bio, Inc. 02 Feb 2023 1 $0 4 President and CEO, Director 06 Feb 2023, 16:26
/report/000089924322039024-allen-andrew-r-2022-12-15 TCR2 THERAPEUTICS INC. 15 Dec 2022 1 $0 4 Director 19 Dec 2022, 16:24
/report/000120919122040258-allen-andrew-r-2022-07-01 Sierra Oncology, Inc. 01 Jul 2022 6 -$90,750 4 Director, 10%+ Owner 01 Jul 2022, 16:38
/report/000156761922008708-allen-andrew-r-2022-01-31 Gritstone bio, Inc. 31 Jan 2022 2 $0 4 President and CEO, Director 20 Apr 2022, 16:20
/report/000120919121069022-allen-andrew-r-2021-12-09 TCR2 THERAPEUTICS INC. 09 Dec 2021 1 $0 4 Director 10 Dec 2021, 15:27
/report/000089924321023872-allen-andrew-r-2021-06-11 Epizyme, Inc. 11 Jun 2021 2 $0 4 Director 15 Jun 2021, 16:37
/report/000120919121039090-allen-andrew-r-2021-06-08 Sierra Oncology, Inc. 08 Jun 2021 1 $0 4 Director 09 Jun 2021, 10:31
/report/000156761921020853-allen-andrew-r-2021-01-07 Gritstone bio, Inc. 07 Jan 2021 1 $0 4 President and CEO, Director 19 Nov 2021, 15:28